Horizon Europe is the ninth European Research and Innovation Framework programme (2021-2027). In the wake of the COVID-19 pandemic, it is one of the key instruments of the European Union's efforts to steer and accelerate Europe's recovery, preparedness and resilience. In the context of a new European Research Area for research and innovation, it aims to strengthen Europe's knowledge base through frontier research, spur breakthrough innovation and support the development and demonstration of innovative solutions, and help restore industrial leadership and open strategic autonomy.

The first Horizon Europe Strategic Plan (2021-2024) which sets out key strategic orientations for the support of research and innovation, was adopted on 15 March 2021.

Activity under Horizon Europe is primarily organised under three 'pillars':

Pillar I - Excellent Science

Pillar II - Global Challenges and European Industrial Competitiveness

Pillar III - Innovative Europe

As part of Pillar II, the EU has identified six clusters to help accelerate and steer Europe's digital and green transitions:

Cluster 1 - Health

Cluster 2 - Culture, Creativity and Inclusive Society

Cluster 3 - Civil Security for Society

Cluster 4 - Digital, Industry and Space

Cluster 5 - Climate, Energy and Mobility

Cluster 6 - Food, Bioeconomy, Natural Resources, Agriculture and Environment

This report covers research funding support available under Cluster 1 - Health.

Aim

The aim of the Health cluster is to increase Europe's autonomy in delivering health care by contributing to safer, trusted, more effective and efficient, affordable and cost-effective tools, technologies and digital solutions for improved (personalised) health promotion and disease prevention, diagnosis, treatment and monitoring for better health outcomes and well-being, by integrating people in the design and decision-making, based on expected health outcomes and potential risks involved.

It will also contribute to a health-related industry in the EU that is more competitive and sustainable, ensuring European leadership in breakthrough health technologies and open strategic autonomy in essential medical supplies and digital technologies, contributing to job creation and economic growth, in particular small and medium-sized enterprises (SMEs).

Topics 2022 (single and two stage): 

Destination 1: Staying healthy in a rapidly changing society

RIA: HORIZON-HLTH-2022-STAYHLTH-01-01-two-stage: Boosting mental Health in Europe in times of change. Two stage. 01 Feb 2022 (First Stage), 06 Sep 2022 (Second Stage)

RIA: HORIZON-HLTH-2022-STAYHLTH-01-04-two-stage: Trustworthy artificial intelligence (AI) tools to predict the risk of chronic non-communicable diseases and/or their progression. Two stage. 01 Feb 2022 (First Stage), 06 Sep 2022 (Second Stage)

RIA: HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage: Prevention of obesity throughout the life course. Two stage. 01 Feb 2022 (First Stage), 06 Sep 2022 (Second Stage)

RIA: HORIZON-HLTH-2022-STAYHLTH-02-01: Personalised blueprint of chronic inflammation in health-to-disease transition. Single stage. Deadline 21 Apr 2022

Destination 2. Living and working in a health-promoting environment

RIA: HORIZON-HLTH-2022-ENVHLTH-04-01: Methods for assessing health-related costs of environmental stressors. Single stage. Deadline 21 Apr 2022

Destination 3. Tackling diseases and reducing disease burden

RIA: HORIZON-HLTH-2022-DISEASE-06-02-two-stage: Pre-clinical development of the next generation of immunotherapies for diseases or disorders with unmet medical needs. 01 Feb 2022 (First Stage), 06 Sep 2022 (Second Stage)

RIA: HORIZON-HLTH-2022-DISEASE-06-03-two-stage: Vaccines 2.0 - developing the next generation of vaccines. 01 Feb 2022 (First Stage), 06 Sep 2022 (Second Stage)

RIA: HORIZON-HLTH-2022-DISEASE-06-04-two-stage: Development of new effective therapies for rare diseases. 01 Feb 2022 (First Stage), 06 Sep 2022 (Second Stage)

CSA: HORIZON-HLTH-2022-DISEASE-07-01: Support for the functioning of the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). Single stage. Deadline 21 Apr 2022

RIA: HORIZON-HLTH-2022-DISEASE-07-02: Pandemic preparedness. Single stage. Deadline 21 Apr 2022

RIA: HORIZON-HLTH-2022-DISEASE-07-03: Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD). Single stage. Deadline 21 Apr 2022

COFUND: HORIZON-HLTH-2022-DISEASE-03-01: European partnership fostering a European Research Area (ERA) for health research. Single stage. Deadline 21 Apr 2022

Destination 4. Ensuring access to innovative, sustainable and high-quality health care

PCP: HORIZON-HLTH-2022-CARE-08-02: Pre-commercial research and innovation procurement (PCP) for building the resilience of health care systems in the context of recovery. Single stage. Deadline 21 Apr 2022

PPI: HORIZON-HLTH-2022-CARE-08-03: Public procurement of innovative solutions (PPI) for building the resilience of health care systems in the context of recovery. Single stage. Deadline 21 Apr 2022

RIA: HORIZON-HLTH-2022-CARE-08-04: Better financing models for health systems. Single stage. Deadline 21 Apr 2022

COFUND: HORIZON-HLTH-2022-CARE-10-01: European partnership on transforming health and care systems. Single stage. Deadline 21 Apr 2022

Destination 5. Unlocking the full potential of new tools, technologies and digital solutions for a healthy society

RIA: HORIZON-HLTH-2022-TOOL-11-01: Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers. Single stage. Deadline 21 Apr 2022

RIA: HORIZON-HLTH-2022-TOOL-11-02: New methods for the effective use of real-world data and/or synthetic data in regulatory decision-making and/or in health technology assessment. Single stage. Deadline 21 Apr 2022

RIA: HORIZON-HLTH-2022-TOOL-12-01-two-stage: Computational models for new patient stratification strategies. Two stage. 01 Feb 2022 (First Stage), 06 Sep 2022 (Second Stage)

Destination 6. Maintaining an innovative, sustainable and globally competitive health industry

RIA: HORIZON-HLTH-2022-IND-13-01: Enhancing cybersecurity of connected medical devices. Single stage. Deadline 21 Apr 2022

RIA: HORIZON-HLTH-2022-IND-13-02: Scaling up multi-party computation, data anonymisation techniques, and synthetic data generation. Single stage. Deadline 21 Apr 2022

RIA: HORIZON-HLTH-2022-IND-13-03: New pricing and payment models for cost-effective and affordable health innovations. Single stage. Deadline 21 Apr 2022

CSA: HORIZON-HLTH-2022-IND-13-04: Setting up a European Smart Health Innovation Hub. Single stage. Deadline 21 Apr 2022

CSA: HORIZON-HLTH-2022-IND-13-05: Setting up a European Electronic Health Record Exchange Format (EEHRxF) Ecosystem. Single stage. Deadline 21 Apr 2022

Eligibility

Any legal entity may participate in an action provided that the conditions laid down in the Rules of Participation have been met as well as any conditions laid down in the relevant work programme or work plan.

Applicants must be established in:

• A Member State of the European Union, including their outermost regions
• Overseas Countries and Territories (OCTs) linked to the Member States
• Non-EU countries associated to Horizon Europe

Applications to Horizon Europe calls and topics must be submitted via the European Commission Funding and Tenders Portal.

More info at: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2021-2022/wp-4-health_horizon-2021-2022_en.pdf

In case of interest, please contact internacional(ELIMINAR)@fsjd.org